Deutsche Bank raised its price target for UnitedHealth to $127 after hosting meetings with management. Deutsche says management remains upbeat about earnings growth acceleration in 2016. It notes UnitedHealth remains a top pick with a Buy rating.
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Biohaven Pharmaceutical... To see the rest of the story go to thefly.com. See Story Here
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here